|
GB8809316D0
(en)
|
1987-05-11 |
1988-05-25 |
Ici America Inc |
Heterocyclic ketones
|
|
US5672582A
(en)
|
1993-04-30 |
1997-09-30 |
Merck & Co., Inc. |
Thrombin inhibitors
|
|
ZA951618B
(en)
|
1994-03-04 |
1996-08-27 |
Lilly Co Eli |
Antithrombotic agents
|
|
US5726159A
(en)
|
1994-03-04 |
1998-03-10 |
Eli Lilly And Company |
Antithrombotic agents
|
|
ZA951617B
(en)
|
1994-03-04 |
1997-02-27 |
Lilly Co Eli |
Antithrombotic agents.
|
|
US5707966A
(en)
|
1994-03-04 |
1998-01-13 |
Eli Lilly And Company |
Antithrombotic agents
|
|
US5705487A
(en)
|
1994-03-04 |
1998-01-06 |
Eli Lilly And Company |
Antithrombotic agents
|
|
HU221197B1
(en)
|
1994-06-02 |
2002-08-28 |
Aventis Pharma Inc |
Elastase inhibitor tripeptides and pharmaceutical compositions comprising thereof
|
|
JPH0820597A
(ja)
|
1994-07-07 |
1996-01-23 |
Meiji Seika Kaisha Ltd |
トロンビン阻害作用を有する複素環カルボニル化合物
|
|
US5618792A
(en)
|
1994-11-21 |
1997-04-08 |
Cortech, Inc. |
Substituted heterocyclic compounds useful as inhibitors of (serine proteases) human neutrophil elastase
|
|
US5914319A
(en)
|
1995-02-27 |
1999-06-22 |
Eli Lilly And Company |
Antithrombotic agents
|
|
US5710130A
(en)
|
1995-02-27 |
1998-01-20 |
Eli Lilly And Company |
Antithrombotic agents
|
|
CA2176414A1
(en)
|
1995-05-18 |
1996-11-19 |
S. David Kimball |
Acyl guanidine and amidine prodrugs
|
|
US5827860A
(en)
|
1995-06-07 |
1998-10-27 |
Ortho Pharmaceutical Corporation |
Peptidyl heterocycles useful in the treatment of thrombin related disorders
|
|
US6022861A
(en)
|
1995-06-07 |
2000-02-08 |
Cor Therapeutics, Inc. |
Ketoheterocyclic inhibitors of factor Xa
|
|
US6211154B1
(en)
|
1995-06-07 |
2001-04-03 |
Cor Therapeutics, Inc. |
Ketoheterocyclic inhibitors of factor Xa
|
|
US5523308A
(en)
|
1995-06-07 |
1996-06-04 |
Costanzo; Michael J. |
Peptidyl heterocycles useful in the treatment of thrombin related disorders
|
|
US6069130A
(en)
|
1995-06-07 |
2000-05-30 |
Cor Therapeutics, Inc. |
Ketoheterocyclic inhibitors of factor Xa
|
|
US5827866A
(en)
|
1995-06-07 |
1998-10-27 |
Ortho Pharmaceutical Corporation |
Peptidyl heterocycles useful in the treatment of thrombin related disorders
|
|
IL119466A
(en)
|
1995-11-03 |
2001-08-26 |
Akzo Nobel Nv |
Thrombin inhibitors, their preparation and pharmaceutical compositions containing them
|
|
TW523513B
(en)
|
1996-03-01 |
2003-03-11 |
Akzo Nobel Nv |
Serine protease inhibitors
|
|
NZ332740A
(en)
|
1996-06-18 |
2000-05-26 |
Warner Lambert Co |
heterocyclically substituted carbamate or sulphonamide derivatives
|
|
IL121474A0
(en)
|
1996-08-23 |
1998-02-08 |
Akzo Nobel Nv |
Thrombin inhibitors
|
|
CZ298749B6
(cs)
|
1996-10-18 |
2008-01-16 |
Vertex Pharmaceuticals Incorporated |
Inhibitory serinových proteáz a farmaceutické prostředky s jejich obsahem
|
|
AU734615B2
(en)
|
1996-12-06 |
2001-06-21 |
Cortech, Inc. |
Serine protease inhibitors
|
|
US6004933A
(en)
|
1997-04-25 |
1999-12-21 |
Cortech Inc. |
Cysteine protease inhibitors
|
|
PL336589A1
(en)
|
1997-05-02 |
2000-07-03 |
Akzo Nobel Nv |
Serinic protease inhibitors
|
|
EP1012180B1
(en)
|
1997-08-11 |
2004-12-01 |
Boehringer Ingelheim (Canada) Ltd. |
Hepatitis c inhibitor peptide analogues
|
|
US6323219B1
(en)
|
1998-04-02 |
2001-11-27 |
Ortho-Mcneil Pharmaceutical, Inc. |
Methods for treating immunomediated inflammatory disorders
|
|
EP1114822A3
(en)
|
1998-06-03 |
2002-11-13 |
Cortech Inc. |
Indoles and tetrahydroisoquinolines containing alpha-keto oxadiazoles as serine protease inhibitors
|
|
AR022061A1
(es)
|
1998-08-10 |
2002-09-04 |
Boehringer Ingelheim Ca Ltd |
Peptidos inhibidores de la hepatitis c, una composicion farmaceutica que los contiene, el uso de los mismos para preparar una composicion farmaceutica, el uso de un producto intermedio para la preparacion de estos peptidos y un procedimiento para la preparacion de un peptido analogo de los mismos.
|
|
US6323180B1
(en)
|
1998-08-10 |
2001-11-27 |
Boehringer Ingelheim (Canada) Ltd |
Hepatitis C inhibitor tri-peptides
|
|
US6242422B1
(en)
|
1998-10-22 |
2001-06-05 |
Idun Pharmacueticals, Inc. |
(Substituted)Acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
KR20000047461A
(ko)
|
1998-12-29 |
2000-07-25 |
성재갑 |
트롬빈 억제제
|
|
HUP0201295A3
(en)
*
|
1999-01-27 |
2002-10-28 |
Ortho Mcneil Pharm Inc |
Peptidyl heterocyclic ketones useful as tryptase inhibitors
|
|
JP2000256396A
(ja)
|
1999-03-03 |
2000-09-19 |
Dainippon Pharmaceut Co Ltd |
複素環式化合物およびその中間体ならびにエラスターゼ阻害剤
|
|
GB9929552D0
(en)
|
1999-12-14 |
2000-02-09 |
Proteus Molecular Design |
Compounds
|
|
WO2001002601A2
(en)
|
1999-07-07 |
2001-01-11 |
Du Pont Pharmaceuticals Company |
Cell-based assay systems for examining hcv ns3 protease activity
|
|
GB9923710D0
(en)
|
1999-10-08 |
1999-12-08 |
Proteus Molecular Design |
Chemical compounds
|
|
WO2001040262A1
(en)
|
1999-12-03 |
2001-06-07 |
Bristol-Myers Squibb Pharma Company |
Alpha-ketoamide inhibitors of hepatitis c virus ns3 protease
|
|
MXPA03000627A
(es)
|
2000-07-21 |
2004-07-30 |
Schering Corp |
Nuevos peptidos como inhibidores de proteasa serina-ns3 del virus de la hepatitis c.
|
|
US7244721B2
(en)
|
2000-07-21 |
2007-07-17 |
Schering Corporation |
Peptides as NS3-serine protease inhibitors of hepatitis C virus
|
|
SV2003000617A
(es)
|
2000-08-31 |
2003-01-13 |
Lilly Co Eli |
Inhibidores de la proteasa peptidomimetica ref. x-14912m
|
|
WO2002079146A2
(en)
|
2001-03-02 |
2002-10-10 |
Bristol-Myers Squibb Company |
Compounds useful as modulators of melanocortin receptors and pharmaceutical compositions comprising same
|
|
CA2449504A1
(en)
|
2001-07-11 |
2003-01-23 |
Vertex Pharmaceuticals Incorporated |
Bridged bicyclic serine protease inhibitors
|
|
CA2462200A1
(en)
|
2001-08-10 |
2003-02-20 |
Palatin Technologies, Inc. |
Peptidomimetics of biologically active metallopeptides
|
|
EP1480999A2
(en)
|
2002-02-08 |
2004-12-01 |
Idun Pharmaceuticals |
(substituted)acyl dipeptidyl inhibitors of the ice/ced-3 family of cysteine proteases
|
|
US7019019B2
(en)
|
2002-12-23 |
2006-03-28 |
Dendreon Corporation |
Matriptase inhibitors and methods of use
|
|
US7205384B2
(en)
*
|
2003-08-05 |
2007-04-17 |
Ortho-Mcneil Pharmaceutical Inc. |
Process for preparing peptidyl heterocyclic ketone derivatives
|
|
PE20050374A1
(es)
|
2003-09-05 |
2005-05-30 |
Vertex Pharma |
Inhibidores de proteasas de serina, en particular proteasa ns3-ns4a del vhc
|
|
CA2541634A1
(en)
|
2003-10-10 |
2005-04-28 |
Vertex Pharmaceuticals Incorporated |
Inhibitors of serine proteases, particularly hcv ns3-ns4a protease
|
|
CA2549167A1
(en)
|
2003-12-11 |
2005-06-30 |
Schering Corporation |
Inhibitors of hepatitis c virus ns3/ns4a serine protease
|
|
WO2005076886A2
(en)
*
|
2004-02-05 |
2005-08-25 |
Irm Llc |
Prostasin substrates and inhibitors
|
|
US7192957B2
(en)
|
2004-02-27 |
2007-03-20 |
Schering Corporation |
Compounds as inhibitors of hepatitis C virus NS3 serine protease
|
|
ES2530056T3
(es)
|
2004-03-24 |
2015-02-26 |
Shire Orphan Therapies Gmbh |
Nuevos compuestos para la inhibición de la angiogénesis y su uso
|
|
CN1984922A
(zh)
|
2004-05-20 |
2007-06-20 |
先灵公司 |
用作丙型肝炎病毒ns3丝氨酸蛋白酶抑制剂的取代脯氨酸
|
|
WO2006006644A1
(ja)
|
2004-07-14 |
2006-01-19 |
Kyowa Hakko Kogyo Co., Ltd. |
複素環式化合物
|
|
GB0507577D0
(en)
|
2005-04-14 |
2005-05-18 |
Novartis Ag |
Organic compounds
|
|
US20060275366A1
(en)
|
2005-06-02 |
2006-12-07 |
Schering Corporation |
Controlled-release formulation
|
|
RU2419625C2
(ru)
|
2006-05-23 |
2011-05-27 |
Айрм Ллк |
Соединения и композиции в качестве ингибиторов протеазы, активирующей каналы
|
|
US7951823B2
(en)
*
|
2006-05-23 |
2011-05-31 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|
|
RS51644B
(sr)
|
2007-01-10 |
2011-10-31 |
Irm Llc. |
Jedinjenja i preparati kao inhibitori kanal aktivirajuće proteaze
|
|
KR20090108131A
(ko)
|
2007-02-09 |
2009-10-14 |
아이알엠 엘엘씨 |
채널 활성화 프로테아제 억제제로서의 화합물 및 조성물
|
|
EP2117541A1
(en)
|
2007-02-09 |
2009-11-18 |
Irm Llc |
Compounds and compositions as channel activating protease inhibitors
|